M. Paubertbraquet et al., INHIBITION OF BFGF AND EGF-INDUCED PROLIFERATION OF 3T3 FIBROBLASTS BY EXTRACT OF PYGEUM-AFRICANUM (TADENAN(R)), Biomedicine & pharmacotherapy, 48, 1994, pp. 43-47
Citations number
15
Categorie Soggetti
Pharmacology & Pharmacy","Medicine, Research & Experimental
An extract of Pygeum africanum bark (Tadenan(R)) is prescribed for old
er men suffering from micturitional difficulties due to benign prostat
ic hyperplasia (BPH). Its mechanism of action is not completely unders
tood. Basic fibroblast growth factor (bFGF) probably plays a role in t
he development of BPH. We have examined the effects of P africanum ext
ract on basal cell proliferation and on the proliferation induced by b
FGF, epidermal growth factor (EGF) and insulin-like growth factor-1 (I
GF-1). The proliferation of 3T3 fibroblasts was measured by the incorp
oration of tritiated methylthymidine and staining nuclei with crystal
violet. P africanum extract slightly inhibited the basal growth of fib
roblasts. However, it had a much larger inhibitory effect on cell prol
iferation induced by bFGF with 0.5 mu g/ml, and the effect was signifi
cant at 1 mu g/ml. Pygeum africanum extract also inhibited cell prolif
eration induced with EGF, but to a lesser extent. This suggests that t
he therapeutic effect of P africanum extract may be partly due to inhi
bition of cell growth induced by certain growth factors.